 |
|
|
|
|
| |
|
ARTES Biotechnology GmbH, a profitable German biotech company, is offering
R&D services for recombinant strain development in microbial expression
systems. The champion amongst them is the patent protected yeast Hansenula
polymorpha. ARTES Biotechnology is holding worldwide exclusive licensing
rights on this superior expression technology for various application
fields.
ARTES' staff has more than 15 years experience in commercial
project management in heterologous gene expression and process development,
especially in the handling and exploitation of the Hansenula polymorpha
technology platform.
ARTES' customers include multinational players such as DSM Nutritional
Products (previously Roche) and Danisco as well as small and middle sized
companies.
|
|
|
| |
 |
ARTES has strategic collaboration partners
around the world to offer customer tailored service packages in the field
of recombinant protein production such as:
- gene analysis and design
- production strain selection
- fermentation development
- downstream processing
- process upscale
- large scale cGMP production
With its collaboration network ARTES is the ideal partner for complete
research and development from gene to product and for the implementation
of your production process. To ensure highest quality in project progress
and documentation ARTES offers consultation and supervision service during
the defined project period.
For having continuous access to the most recent scientific investigation
results, ARTES in addition has a large international academic network.
Especially in the field of the Hansenula polymorpha yeast expression technology,
ARTES is in permanent contact with members of the Hansenula polymorpha
Worldwide Network (HPWN) which has been established in 2000.
|
|
| ARTES - In Touch with Experts
Around the World |
|
|
| |
|
 |
|
Our partner in small scale cultivation |
| |
|
|
 |
|
Your access point for the Hansenula technology
and fermentation services in the US |
| |
|
|
 |
|
Experts in sequence optimisation and gene synthesis |
| |
|
|
 |
|
Collaboration on microbial expression systems |
|
|
|
 |
|
Our partner for the Arxula technology |
|
|
|
 |
|
Our partner in high throughput fermentations |
| |
|
|
 |
|
Our partner in protein and biomolecules analysis |
| |
|
|
 |
|
Our partner in product development |
| |
|
|
 |
|
Our partner in large scale cGMP production |
|
|
|
IP Portfolio 
